# VIJOICE

NDC: 0078-1175
Generic name: alpelisib
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GRANULE
Routes: ORAL
Marketing started: 20240424

FDA application: NDA218466

## Active ingredients

- ALPELISIB: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-1175"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-1175
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=638069a4-aee0-46c9-9e21-54ad449c163c